Recon: FDA approves Antares’ oral testosterone drug; Europe’s biotech industry face tough times, restructuring amid ‘dwindling’ cash
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy